Mirabgeorn
NDC 67184-0572, mirabegron, tablet, film coated, extended release, from Qilu Pharmaceutical Co., Ltd..
- Product NDC
- 67184-0572
- Status
- Listed
- Labeler
- Qilu Pharmaceutical Co., Ltd.
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA217989
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0572 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MIRABEGRON50 mg/1
Pharmacologic classes
Adrenergic beta3-Agonists [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]; beta3-Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67184-0572-1 | 67184057201 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (67184-0572-1) |
| 67184-0572-2 | 67184057202 | 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (67184-0572-2) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/98247602-29b9-4621-8eeb-519e40b883b9
Use it
Look up 67184-0572 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0572 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67184-0572. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.